Cingulate Inc. vs Rallybio Corporation
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Rallybio Corporation is the larger company by market value: $88 M against $83 M for Cingulate Inc., 1.1 times as much (market caps of Oct 28, 2026 for Cingulate Inc. and Oct 27, 2026 for Rallybio Corporation).
- Both made a net loss: $22 M for Cingulate Inc. and $9 M for Rallybio Corporation.
Market value, the same start = 100
From Dec 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Cingulate Inc. CING · #19,432 in the world | Rallybio Corporation RLYB · #19,150 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | 2018 |
| Size | ||
| Market cap | $83 M | $88 M |
| Revenue | — | $1 M |
| Net income | $-22 M | $-9 M▲ best |
| Employees | — | 14 |
| Valuation | ||
| Price to sales | — | 103× |
| Price to book | 33.0× | 1.5× |
| Free cash flow yield | -21.0%▲ best | -55.8% |
| Profitability | ||
| Return on equity | -450.4% | -15.0%▲ best |
| Financial strength | ||
| Interest cover | -22.2× | — |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Cingulate Inc. or Rallybio Corporation?
Rallybio Corporation is the larger company by market value: $88 M against $83 M for Cingulate Inc., 1.1 times as much (market caps of Oct 28, 2026 for Cingulate Inc. and Oct 27, 2026 for Rallybio Corporation).
Which makes more money, Cingulate Inc. or Rallybio Corporation?
Both made a net loss: $22 M for Cingulate Inc. and $9 M for Rallybio Corporation.